FDA says product mislabeled, misleading

Nov 20, 2007

U.S. regulators seized about $2 million of potentially harmful eye products that contain a drug ingredient officials said could lead to decreased vision.

At the request of the U.S. Food and Drug Administration, federal marshals seized 12,682 tubes of Age Intervention Eyelash, a product that may, in some users, lead to decreased vision, the FDA said in a news release. Authorities said the seized tubes could have generated about $2 million in sales.

The FDA said it considered Age Intervention Eyelash an unapproved and improperly branded drug because Jan Marini Skin Research promoted the product to increase eyelash growth. The regulator said it also considered the product to be an adulterated cosmetic because it contains bimatoprost, an active ingredient in an FDA-approved drug used to treat elevated pressure inside the eye.

The FDA said patients taking the prescription drug may have an increased risk of optic nerve damage if they use Age Intervention Eyelash. Because it contains bimatoprost, Age Intervention Eyelash also may cause adverse effects in some people, including macular edema and uveitis.

The FDA recommended that consumers, dermatologists and estheticians discontinue using Age Intervention Eyelash and discard the product.

Copyright 2007 by United Press International

Explore further: Suboptimal prescribing attitudes could signal personal distress

Related Stories

World's second most endangered turtle on road to recovery

11 minutes ago

Wildlife Conservation Society (WCS) and the Turtle Survival Alliance (TSA) announced today that 60 captive-raised Myanmar roofed turtles—a species once thought extinct—have been released into their native ...

The difference between "use-by" "sell-by" and "best-by" dates

12 minutes ago

Confusion over date labeling leads to billions of pounds of food waste every year. Bob Brackett, PhD CFS, Director of the Institute for Food Safety and Health at the Illinois Institute of Technology and IFT spokesperson explains ...

Modular Robotic Vehicle developed at Johnson Space Center

1 hour ago

We all know Google's star act for driving's future with its self-driving car. What if NASA were to step up and give us its rendition of a self-driving vehicle? A new video reveals how NASA handles the role. NASA actually ...

Recommended for you

Selecting the right tool for the job

Apr 14, 2015

Randomized clinical trials of new drugs have long been considered the "gold standard" in determining safety and efficacy before drugs, biologics, vaccines or devices are introduced to the general public. However, in the case ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.